Serum Neopterin as a Prognostic Indicator in Patients with Gastric Carcinoma

REFERENCES

• Fuchs D, Weiss G, Wachter H. Neopterin, biochemistry and clinical use as a marker for cellular immune reactions. Int Arch Allergy Immunol. 1993;101:1–6.
   PubMed Web of Science ®Google Scholar
• Wachter H, Fuchs D, Hausen A, Neopterin as marker for activation of cellular immunity: immunologic basis and clinical application. Adv Clin Chem. 1989;27:81–141.
   PubMed Web of Science ®Google Scholar
• Abate G, Comella P, Marfella A, Prognostic relevance of urinary neopterin in non-Hodgkin's lymphoma. Cancer (Philadelphia). 1989;63:484–489.
   PubMed Web of Science ®Google Scholar
• Denz H, Griinewatd K, Thaler J, Urinary neopterin as a prognostic marker in haematological neoplasias. Pteridines. 1989;1:167–170.
   Google Scholar
• Reibnegger G, Krainer M, Herold M, Predictive value of interleukin-6 and neopterin in patients with multiple myeloma. Cancer Res. 1991;51:6250–6253.
   PubMed Web of Science ®Google Scholar
• Reibnegger GJ, Bichler AH, Dapunt O, Neopterin as a prognostic indicator in patients with carcinoma of the uterine cervix. Cancer Res. 1986;46:950–955.
   PubMed Web of Science ®Google Scholar
• Reibnegger G, Hetzel H, Fuchs D, Clinical significance of neopterin for prognosis and follow-up in ovarian cancer. Cancer Res. 1987;47:4977–4981.
   PubMed Web of Science ®Google Scholar
• Prommegger R, Widner B, Murr C, Neopterin: a prognostic variable in operations for lung cancer. Ann Thorac Surg. 2000;70:1861–1864.
   PubMed Web of Science ®Google Scholar
• Melichar B, Solichová D, Melicharová K, Urinary neopterin in patients with advanced colorectal carcinoma. Int J Biol Markers. 2006;21:190–198.
   PubMed Web of Science ®Google Scholar
• Weiss G, Kronberger P, Conrad F, Neopterin and prognosis in patients with adenocarcinoma of the colon. Cancer Res. 1993;53:260–265.
   PubMed Web of Science ®Google Scholar
• Manes G, Spada OA, Rabitti PG, Neopterin serum levels in pancreatic adenocarcinoma. Int J Pancreatol. 1999;25:31–37.
   PubMedGoogle Scholar
• Yildirim Y, Gunel N, Coskun U, Serum neopterin levels in patients with breast cancer. Med Oncol. 2008;25(4):403–407.
   PubMed Web of Science ®Google Scholar
• Melichar B, Solichová D, Svobodová I, Urinary neopterin in patients with liver tumours. Tumouri. 2006;92:318–322.
   PubMed Web of Science ®Google Scholar
• Murr C, Berchtold J, Norer B, Neopterin as a prognostic parameter in patients with squamous-cell carcinomas of the oral cavity. Int J Cancer. 1998;79:476–480.
   PubMed Web of Science ®Google Scholar
• Melichar B, Solichová D, Svobodová I, Neopterin in renal cell carcinoma: inhalational administration of interleukin-2 is not accompanied by a rise of urinary neopterin. Luminescence. 2005;20:311–314.
   PubMed Web of Science ®Google Scholar
• Thiounn N, Pages F, Flam T, IL-6 is a survival prognostic factor in renal cell carcinoma. Immunol Lett. 1997;58:121–124.
   PubMed Web of Science ®Google Scholar
• Negrier S, Perol D, Menetrie-Caux C, Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: prognostic value of interleukin-6—from the Groupe Francais d'Immunotherapie. J Clin Oncol. 2004;22:2371–2378.
   PubMed Web of Science ®Google Scholar
• Melichar B, Solichova D, Svobodova D, Urinary neopterin in patients with upper gastrointestinal, biliary and pancreatic carcinomas. Pteridines. 2006;17:20–24.
   Web of Science ®Google Scholar
• Hoffmann G, Wirleitner B, Fichs D. Potential role of immune system activation-associated production of neopterin derivatives in humans. Inflamm Res. 2003;52:313–321.
   PubMed Web of Science ®Google Scholar
• Weiss G, Willeit J, Kiechl S, Increased concentration of neopterin in carotid atherosclerosis. Atherosclerosis. 1994;106:263–271.
   PubMed Web of Science ®Google Scholar
• Kronberger P, Weiss G, Tschmelitsch J, Predictive value of urinary neopterin in patients with lung cancer. Eur J Clin Chem Clin Biochem. 1995;33:831–837.
   PubMedGoogle Scholar
• Kawasaki H, Watanabe H, Yamada S, Prognostic significance of urinary neopterin levels in patients with hepatocellular carcinoma. Tohoku J Exp Med. 1988;155:311–318.
   PubMed Web of Science ®Google Scholar
• Melichar B, Solichova D, Freedman RS. Neopterin as an indicator of immune activation and prognosis in patients with gynecological malignancies. Int J Gynecol Cancer. 2006;16:240–252.
   PubMed Web of Science ®Google Scholar
• Lissoni P, Tisi E, Brivio F, Increase in soluble interleukin-2 receptor and neopterin serum levels during immunotherapy of cancer with interleukin-2. Eur J Cancer. 1991;27:1014–1016.
   PubMed Web of Science ®Google Scholar
• Aulitzky W, Gastl G, Aulitzky WE, Interferon-γ for the treatment of metastatic renal cancer: dose-dependent microglobulin and neopterin responses. Immunobiology. 1987;176:85–95.
   PubMed Web of Science ®Google Scholar
• Urba WJ, Kopp WC, Clark JW, The in vivo immunomodulatory effects of recombinant interferon-γ plus recombinant tumour necrosis factor-α. J Clin Oncol. 1991;9:1831–1839.
   PubMed Web of Science ®Google Scholar
• Chiang J, Gloff CA, Yoshizawa CN, Pharmacokinetics of recombinant human interferon-β in healthy volunteeras and its effect on serum neopterin. Pharm Res. 1993;10:567–572.
   PubMed Web of Science ®Google Scholar
• Crispino S, Lissoni P, Ardizzola A, Effects of granulocyte—macrophage colony stimulating factor on soluble interleukin-2 receptor serum levels and their relation to neopterin and tumour necrosis factor-α in cancer patients. J Biol Regul Homeost Agents. 1993;7:92–94.
   PubMed Web of Science ®Google Scholar
• Motzer RJ, Rakhit A, Thompson JA, Randomized multicenter phase-II trial of subcutaneous recombinant human interleukin 12 vs. interferon α for patients with advanced renal cell carcinoma. J Interferon Cytokine Res. 2001;21:257–263.
   PubMed Web of Science ®Google Scholar
• Freedman RS, Kudelka AP, Kavanagh JJ, Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumour-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma. Clin Cancer Res. 2000;6:2268–2278.
   PubMed Web of Science ®Google Scholar
• Henderson DC, Sheldon J, Riches P, Cytokine induction of neopterin production. Clin Exp Immunol. 1991;83:479–482.
   PubMed Web of Science ®Google Scholar
• Thiounn N, Pages F, Flam T, IL-6 is a survival prognostic factor in renal cell carcinoma. Immunol Lett. 1997;58:121–124.
   PubMed Web of Science ®Google Scholar
• Nagaoka S, Yoshida T, Akiyoshi J, Serum C-reactive protein levels predict survival in hepatocellular carcinoma. Liver Int. 2007;27:1091–1097.
   PubMed Web of Science ®Google Scholar
• Wu CW, Wang SR, Chao MF, Serum interleukin-6 levels reflect disease status of gastric cancer. Am J Gastroenterol. 1996;91:1417–1422.
   PubMed Web of Science ®Google Scholar
• Fuith LC, Daxenbichler G, Dapunt O. CA 125 in the serum and tissue of patients with gynecological disease. Arch Gynecol Obstet. 1987;241:157–164.
   PubMed Web of Science ®Google Scholar
• Rieder J, Jahnke R, Schloesser M, Niric oxide-dependent apoptosis in ovarian carcinoma cell lines. Gynecol Oncol. 2001;82:172–176.
   PubMed Web of Science ®Google Scholar
• Mohamed KH, Mobaster AAMT, Yousef A-R I, BAL neopterin: a novel marker for cell-mediated immunity in patients with pulmonary tuberculosis and lung cancer. Chest. 2001;119:776–780.
   PubMed Web of Science ®Google Scholar
• Widner B, Baier-Bitterlich G, Wede I, Neopterin indicator of oxidative stres and part of the cytotoxic armature of activated macrophages in humans. Pteridines. 1998;9:91–102.
   Web of Science ®Google Scholar
• Hoffmann G, Frede S, Kenn S, Neopterin-induced tumour necrosis factor-α synthesis in vascular smooth muscle cells in vitro. Int Arch Allergy Immunol. 1998;116:240–245.
   PubMed Web of Science ®Google Scholar
• Alleva DG, Burger CJ, Elgert KD. Tumour-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumour-derived IL-10, TGF-beta, and prostaglandin E. J Immunol. 1994;153:1674–1686.
   PubMed Web of Science ®Google Scholar